These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26810908)

  • 21. Risk factors for diabetic macular oedema in type 2 diabetes: A case-control study in a United Kingdom primary care setting.
    Martín-Merino E; Fortuny J; Rivero-Ferrer E; Lind M; Garcia-Rodriguez LA
    Prim Care Diabetes; 2017 Jun; 11(3):288-296. PubMed ID: 28395937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain.
    Ruiz-Moreno JM; Gámez Lechuga M; Calvo P; Merino M; Martín Lorenzo T; Maravilla-Herrera P; Gil Jiménez B; Abraldes MJ
    Ophthalmol Ther; 2024 Jul; 13(7):1937-1953. PubMed ID: 38771462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time to fellow eye involvement in patients with unilateral diabetic macular oedema.
    Alsaloum P; Russell MW; Blaga V; Kuo BL; Wu AK; Liu BJ; Valentim CCS; Xu CM; Muste JC; Kumar M; Singh RP
    Eye (Lond); 2023 Sep; 37(13):2761-2767. PubMed ID: 36732545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitrectomy may prevent the occurrence of diabetic macular oedema.
    Navarro A; Pournaras JA; Hoffart L; Massin P; Ridings B; Conrath J
    Acta Ophthalmol; 2010 Jun; 88(4):483-5. PubMed ID: 19485958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic macular oedema: a clinical overview.
    Girach A; Lund-Andersen H
    Int J Clin Pract; 2007 Jan; 61(1):88-97. PubMed ID: 17229183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal vessel dilatation and elongation precedes diabetic macular oedema.
    Kristinsson JK; Gottfredsdóttir MS; Stefánsson E
    Br J Ophthalmol; 1997 Apr; 81(4):274-8. PubMed ID: 9215053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400µ: a cost-effectiveness analysis from the DIAMONDS trial.
    Mistry H; Maredza M; Campbell C; Lois N;
    BMJ Open; 2023 Oct; 13(10):e067684. PubMed ID: 37852765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review.
    Mehta H; Gillies MC; Fraser-Bell S
    Clin Exp Ophthalmol; 2016 May; 44(4):335-9. PubMed ID: 27061760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of diabetic macular oedema].
    Ernest J
    Vnitr Lek; 2013 Mar; 59(3):194-200. PubMed ID: 23713187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The social cost of depression in the city of Sabadell (Barcelona, Spain) (2007-2008)].
    Pamias Massana M; Crespo Palomo C; Gisbert Gelonch R; Palao Vidal DJ
    Gac Sanit; 2012; 26(2):153-8. PubMed ID: 22055213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Costs of temporary disability in Spain related to diabetes mellitus and its complications].
    Vicente-Herrero MT; Terradillos García MJ; Capdevila García LM; Ramírez Iñiguez de la Torre MV; López-González AA
    Endocrinol Nutr; 2013 Oct; 60(8):447-55. PubMed ID: 23726468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.
    Hsieh YT; Hsieh MC
    Clin Exp Ophthalmol; 2020 May; 48(4):470-476. PubMed ID: 32065699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
    Zhou S; Gao J; Xu X
    Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.
    Ozkiris A; Evereklioglu C; Erkilic K; Dogan H
    Eye (Lond); 2006 Jan; 20(1):13-7. PubMed ID: 15723039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitrectomy for non-ischaemic macular oedema in retinal vein occlusion.
    Hvarfner C; Larsson J
    Acta Ophthalmol Scand; 2006 Dec; 84(6):812-4. PubMed ID: 17083544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of acute postural variation on diabetic macular oedema.
    Vinten M; la Cour M; Lund-Andersen H; Larsen M
    Acta Ophthalmol; 2010 Mar; 88(2):174-80. PubMed ID: 19094166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health care costs and work absenteeism in smokers: study in an urban community.
    Suárez-Bonel MP; Villaverde-Royo MV; Nerín I; Sanz-Andrés C; Mezquida-Arno J; Córdoba-García R
    Arch Bronconeumol; 2015 Dec; 51(12):615-20. PubMed ID: 26198012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with variability in response of diabetic macular oedema after intravitreal triamcinolone.
    Mohamed S; Leung GM; Chan CK; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Lam DS
    Clin Exp Ophthalmol; 2009 Aug; 37(6):602-8. PubMed ID: 19702711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.